Novamind (NM.C) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Novamind (NM.C), a company attempting to capitalize on the psychedelics market boom. Is it real value or a hallucinogenic nightmare?

Enjoy!

Dumpster Fire, Ketamine, Mushrooms, Psychedelics, Roundtable, Series, Today's Analysis, Video

Related Posts

Novamind (NM.CN) Potential Bottom? But I Would Rather Play PSYK.NE.

Novamind’s (NM.C) stock price makes zero sense right now

How NCE’s are becoming a growth tool for psychedelics companies like Field Trip (FTRP.C), Cybin (CYBN.NE), Braxia (BRAX.C) & Novamind (NM.C)

Novamind (NM.C) opens Client Care Center to keep up with demand

Novamind (NM.C) to double the number of clinics in their network

Novamind (NM.C) shares preliminary findings from KAP studies

More on NM.C

Novamind (NM.CN) Potential Bottom? But I Would Rather Play PSYK.NE.

Novamind’s (NM.C) stock price makes zero sense right now

How NCE’s are becoming a growth tool for psychedelics companies like Field Trip (FTRP.C), Cybin (CYBN.NE), Braxia (BRAX.C) & Novamind (NM.C)

Novamind (NM.C) opens Client Care Center to keep up with demand

Novamind (NM.C) to double the number of clinics in their network

Novamind (NM.C) shares preliminary findings from KAP studies

Leave a Reply Cancel reply